期刊
EPIGENOMICS
卷 7, 期 4, 页码 669-680出版社
FUTURE MEDICINE LTD
DOI: 10.2217/EPI.15.20
关键词
beta-cell; butyrate; diabetes; epigenetics; HDAC inhibitors; histone deacetylase; insulin signaling
资金
- National Institute of Pharmaceutical Education and Research, S. A. S. Nagar, Mohali, India
The contribution of epigenetic mechanisms in diabetes mellitus (DM), beta-cell reprogramming and its complications is an emerging concept. Recent evidence suggests that there is a link between DM and histone deacetylases (HDACs), because HDAC inhibitors promote beta-cell differentiation, proliferation, function and improve insulin resistance. Moreover, gut microbes and diet-derived products can alter the host epigenome. Furthermore, butyrate and butyrate-producing microbes are decreased in DM. Butyrate is a short-chain fatty acid produced from the fermentation of dietary fibers by microbiota and has been proven as an HDAC inhibitor. The present review provides a pragmatic interpretation of chromatin-dependent and independent complex signaling/mechanisms of butyrate for the treatment of Type 1 and Type 2 DM, with an emphasis on the promising strategies for its drugability and therapeutic implication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据